Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PCRX

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCRX
DateTimeSourceHeadlineSymbolCompany
12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
08/10/20218:00AMGlobeNewswire Inc.Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021NASDAQ:PCRXPacira BioSciences Inc
08/05/20214:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
08/05/20214:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
08/04/20218:00AMGlobeNewswire Inc.Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual ConferenceNASDAQ:PCRXPacira BioSciences Inc
08/03/20214:32PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PCRXPacira BioSciences Inc
08/03/202111:38AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCRXPacira BioSciences Inc
08/03/20218:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCRXPacira BioSciences Inc
08/03/20218:00AMGlobeNewswire Inc.Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021NASDAQ:PCRXPacira BioSciences Inc
08/02/20218:00AMGlobeNewswire Inc.Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing ProcessNASDAQ:PCRXPacira BioSciences Inc
07/30/20214:19PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PCRXPacira BioSciences Inc
07/29/20217:30AMGlobeNewswire Inc.New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee ArthroplastyNASDAQ:PCRXPacira BioSciences Inc
07/20/20217:30AMGlobeNewswire Inc.Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021NASDAQ:PCRXPacira BioSciences Inc
07/13/20218:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCRXPacira BioSciences Inc
07/13/20218:00AMGlobeNewswire Inc.Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021NASDAQ:PCRXPacira BioSciences Inc
07/06/20216:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/22/20218:00AMGlobeNewswire Inc.Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin AmericaNASDAQ:PCRXPacira BioSciences Inc
06/17/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCRXPacira BioSciences Inc
06/11/20214:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCRXPacira BioSciences Inc
06/10/20216:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20214:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
06/08/20218:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCRXPacira BioSciences Inc
06/08/20218:00AMGlobeNewswire Inc.Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021NASDAQ:PCRXPacira BioSciences Inc
06/04/20215:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCRXPacira BioSciences Inc
05/26/20218:00AMGlobeNewswire Inc.Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve BlockNASDAQ:PCRXPacira BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:PCRX